Span Divergent FY26 Standalone Profit ₹0.73 Crore, Consolidated Loss ₹2.95 Crore

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Span Divergent FY26 Standalone Profit ₹0.73 Crore, Consolidated Loss ₹2.95 Crore
Overview

Span Divergent reported a standalone profit of ₹0.73 crore for FY26 but a consolidated loss of ₹2.95 crore due to subsidiary operations. No dividend was recommended.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Span Divergent Ltd. FY26 Results

Standalone Profit After Tax: ₹0.7264 crore
Consolidated Loss After Tax: ₹-2.9472 crore

Reader Takeaway: Standalone profit hides group losses; monitor subsidiary revival plans.

What just happened

Span Divergent Ltd. announced its financial results for the fiscal year ending March 31, 2026. The company reported a standalone profit after tax of ₹0.7264 crore (₹72.64 lakh). However, on a consolidated basis, the company incurred a loss after tax of ₹2.9472 crore (₹294.72 lakh).

Why this matters

The significant difference between standalone profitability and consolidated losses highlights financial challenges within the company's subsidiaries. The consolidated loss reflects difficulties in the cashew processing and trading segments, which together reported a loss of ₹3.4311 crore. The company also decided not to recommend any dividend for FY26, aiming to retain funds for future business development.

The backstory

Span Divergent operates in segments including cashew processing and trading. The financial results indicate that while the core entity is performing positively, its subsidiaries are facing significant headwinds. Management is implementing revival plans for subsidiaries like Biospan Contamination Control Solution Pvt. Ltd and Biospan Scientific LLP.

What changes now

Investors will be closely watching the execution of the management's turnaround strategy for the subsidiaries. The company expects these subsidiaries to show improved financial health and turn their negative net worth positive in the near term, driven by new product introductions.

Risks to watch

The primary risk lies in the continued underperformance of subsidiaries, which weigh down the consolidated financials. The negative net worth of these subsidiaries poses a risk to the group's overall financial stability. Failure to execute revival plans effectively could prolong the financial stress.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

Standalone Performance (FY26):

  • Revenue from Operations: ₹2,224.2 lakh
  • Profit After Tax: ₹72.64 lakh
  • Basic EPS: ₹1.33

Consolidated Performance (FY26):

  • Revenue from Operations: ₹18,510.8 lakh
  • Loss After Tax: ₹294.72 lakh
  • Basic EPS: ₹-5.38

Segment Performance (Consolidated FY26):

  • Cashew processing revenue: ₹13,675.7 lakh, segment loss: ₹2,692.2 lakh
  • Trading revenue: ₹3,641.6 lakh, segment loss: ₹738.9 lakh

What to track next

Investors should monitor the company's quarterly results to assess the impact of the revival plans on subsidiary performance. The company's ability to improve consolidated profitability and manage its subsidiaries' financial health will be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.